Clinical Trial Update: Effect of Cannabinoid (THC / CBD 50%) on Hyperalgesia in Patients With Deep Endometriosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effect of a THC/CBD (50%) cannabinoid on hyperalgesia in patients with deep endometriosis; status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• Cannabinoid (THC / CBD 50%)

Snippet

Sponsor: David Garcia Cinca | Conditions: Endometriosis | Phase 2 | Status: UNKNOWN